Skip to main content
. Author manuscript; available in PMC: 2017 Nov 15.
Published in final edited form as: ACS Chem Neurosci. 2016 Jul 22;7(9):1283–1291. doi: 10.1021/acschemneuro.6b00156

Figure 1.

Figure 1

In vitro pharmacology of SKY2-23-7 versus SHU9119 in female HEK293 cells. A Schild analysis of SKY2-23-7 at the mMC3R (A) and mMC4R (B). A Schild analysis of SHU9119 at the mMC3R (C) and mMC4R (D). SKY2-23-7 lacks the mMC3R partial agonism commonly seen with known central antagonists such as SHU9119 (A versus C). Data from Doering et. al.22